{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/04/23/3280270/0/en/Otarmeni-lunsotogene-parvec-cwha-Approved-by-FDA-as-First-and-Only-Gene-Therapy-for-Genetic-Hearing-Loss-Regeneron-to-Provide-Otarmeni-for-Free-in-the-U-S.html", "message": "News view counter 678553 successfully enlarged"}